MMe were first described as an obesity-induced ATM state in adipose depots driven by saturated free fatty acids and NOX2-dependent metabolic activation that secretes IL-6 and promotes cancer stem-like properties via GP130/STAT3 signaling [46]. The gene discussed is STAT3; the disease is obesity due to melanocortin 4 receptor deficiency.